PeopleofSuperintelligence

Lab leader

Miles Congreve

Miles Congreve is chief scientific officer of Isomorphic Labs, a new Alphabet bet focused on using artificial intelligence to accelerate drug discovery. He began his career with Glaxo in 1993 and then directed chemistry at Astex, where he helped establish fragment-based drug design. At Heptares he worked on structure-based drug design for GPCRs, and in 2015 he shared the RSC Malcolm Campbell Memorial Prize. TIME recognized him in 2025 on its TIME100 AI list. He is co-inventor of Kisqali (ribociclib), a breast cancer treatment, and has helped design 29 clinically evaluated drugs.

Works
227
Citations
25,991
h-index
44

Publication numbers from OpenAlex, as of 15 October 2026.

Timeline

  1. 1993

    Early GPCR work at Glaxo

    He begins his career with Glaxo in 1993, working on GPCR and enzyme projects in lead optimisation. At Astex he then becomes director of chemistry, where he helps establish fragment-based drug design. His degrees are a BSc in Biological Chemistry from Leicester University and a PhD in Synthetic Chemistry from Cambridge University.

  2. 2015

    A Malcolm Campbell Memorial Prize

    He shares the RSC Malcolm Campbell Memorial Prize in 2015 as vice president of chemistry at Heptares Therapeutics. The award recognizes contributions to GPCR drug discovery made by the company.

  3. By 2022

    Co-inventor of Kisqali

    He has contributed to the design of 20 clinically evaluated drugs and is co-inventor of Kisqali (ribociclib), a marketed treatment for breast cancers.

  4. May 2022

    Chief scientific officer at Isomorphic Labs

    He joins Isomorphic Labs as chief scientific officer in May 2022, coming from the same role at Sosei Heptares, where he has worked on structure-based drug design for GPCRs. The company is a new Alphabet bet focused on the use of artificial intelligence to accelerate drug discovery.

  5. 2025

    A place on TIME100 AI

    TIME's 2025 TIME100 AI list recognizes him as one of the world's most influential people in AI.

  6. Since 2022

    Drug design at Isomorphic Labs

    He is chief scientific officer at Isomorphic Labs, where he has helped design 29 clinically evaluated drugs.

Sources and credits

Photo: We have no published photo of Miles Congreve yet. Send us a free-licensed photo.

  1. Miles Congreve, Vice President, Head - eMedEvents emedevents.com. Checked 15 October 2026.
  2. Isomorphic Labs announces first phase of management team - Isomorphic Labs isomorphiclabs.com. Checked 15 October 2026.
  3. Heptares scientists receive 2015 Malcolm Campbell Memorial Prize manufacturingchemist.com. Checked 15 October 2026.
  4. Malcolm Campbell Memorial Prize winners 2015 – RSC Medicinal Chemistry Blog blogs.rsc.org. Checked 15 October 2026.
  5. Miles Congreve, PhD - Isomorphic Labs isomorphiclabs.com. Checked 15 October 2026.